Status and phase
Conditions
Treatments
About
To evaluate the efficacy, safety and pharmacokinetics profile of KPS-0373 in patients with SCD
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal